The short answer, Garen said, is that we all will. It's important to get all this tracking and reporting data right, and not just to avoid penalties and fines, he added. The data will be used internally by companies to ensure they're compliant with state laws and company policies. And the data can be used beyond even that, as Garen pointed out: “I’ll be looking at it to see what our competitors are doing.”

Then there are the external parties—the media, the HCPs, patients, medical associations, and academic researchers—all of whom will be scouring the data as well to highlight life sciences spend on HCPs on a local, regional, and national level, see where their own physicians rank, and examine how spend patterns do or do not affect HCP behavior.